|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.10 BDT | -1.91% |
|
-8.13% | -23.30% |
| Market Cap | 6.37B 51.4M 44.61M 41.77M 38.21M 72.13M 4.9B 73.07M 489M 192M 2.45B 193M 189M 8.14B | P/E 2024 |
231x | P/E 2025 | 182x |
|---|---|---|---|---|---|
| Enterprise Value | 6.67B 53.84M 46.72M 43.75M 40.02M 75.55M 5.13B 76.53M 512M 201M 2.56B 202M 198M 8.53B | EV / Sales 2024 |
12.2x | EV / Sales 2025 | 10.1x |
| Free-Float |
59.39% | Yield 2024 |
0.25% | Yield 2025 | 0.64% |
| 1 day | -1.91% | ||
| 1 week | -8.13% | ||
| Current month | -7.42% | ||
| 1 month | -11.84% | ||
| 3 months | -16.07% | ||
| 6 months | -27.11% | ||
| Current year | -23.30% |
| 1 week | 260 |  | 285 |
| 1 month | 260 | | 313 |
| Current year | 260 | | 391.8 |
| 1 year | 260 | | 587.5 |
| 3 years | 217.2 | | 726.9 |
| 5 years | 75 | | 1,000 |
| 10 years | 44 | | 1,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2013-12-31 | |
| Director of Finance/CFO | - | 2020-11-07 | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2013-12-31 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1983-05-04 |
| Director/Board Member | 45 | 1999-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.91% | -8.13% | -28.80% | -26.83% | 44.01M | |
| +1.89% | -1.49% | +55.62% | +165.18% | 1,043B | |
| -0.24% | -3.22% | +50.51% | +52.02% | 621B | |
| -0.95% | -7.38% | +22.83% | +65.08% | 435B | |
| 0.00% | +0.83% | +42.80% | +37.60% | 361B | |
| +0.58% | -3.51% | +31.12% | +40.54% | 293B | |
| -1.55% | -9.78% | +5.61% | +8.62% | 251B | |
| -0.73% | +4.44% | +34.91% | +66.41% | 220B | |
| -0.24% | -13.15% | -4.02% | -44.69% | 201B | |
| -0.68% | -1.41% | +16.36% | +66.32% | 164B | |
| Average | -0.36% | -4.17% | +22.69% | +43.02% | 358.92B | |
| Weighted average by Cap. | +0.27% | -3.79% | +37.57% | +77.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827M 6.67M 5.79M 5.42M 4.96M 9.37M 636M 9.49M 63.44M 24.9M 318M 25.06M 24.51M 1.06B | 665M 5.36M 4.65M 4.36M 3.99M 7.53M 511M 7.62M 50.98M 20.01M 255M 20.14M 19.7M 850M |
| Net income | 42.33M 341K 296K 277K 254K 479K 32.53M 485K 3.25M 1.27M 16.25M 1.28M 1.25M 54.09M | 35.02M 282K 245K 230K 210K 396K 26.91M 402K 2.69M 1.05M 13.45M 1.06M 1.04M 44.75M |
| Net Debt | 290M 2.34M 2.03M 1.9M 1.74M 3.29M 223M 3.33M 22.27M 8.74M 112M 8.8M 8.61M 371M | 302M 2.44M 2.11M 1.98M 1.81M 3.42M 232M 3.46M 23.17M 9.09M 116M 9.15M 8.95M 386M |
Employees
563
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | BDT 262.10 | -1.91% | 166,630 |
| 26-08-04 | BDT 267.20 | -1.11% | 120,677 |
| 26-08-03 | BDT 270.20 | -0.63% | 353,728 |
| 26-08-02 | BDT 271.90 | -3.96% | 453,147 |
| 26-07-30 | BDT 283.10 | -0.77% | 139,690 |
- Stock Market
- Stocks
- ORIONINFU Stock
Select your edition
All financial news and data tailored to specific country editions
